Skip to main content
OpenTrials
Completed

NCT Number: NCT04971967

Enhancing Partner Services Among Men Who Have Sex With Men Living With HIV

Individuals will participate in a pilot randomized controlled trial (RCT) that implements and evaluates the feasibility, acceptability, and effectiveness of crowdsourced partner services (PS) or conventional PS among Chinese men who have sex with men (MSM) living with HIV.

The pilot RCT will include 120 newly identified MSM HIV cases who were born biologically male, aged 18 years old or older, newly identified as HIV positive, had oral or anal sex with a man, had at least one sexual partner in the previous 6 months and live in Guangzhou. Participants will undergo a series of computer-based interviews (baseline and 2 months after enrollment) and will be randomly assigned into two groups in 2:1 ratio (intervention: control) and receive crowdsourced PS and conventional PS, respectively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–99 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Guangzhou Center for Diseases Control and Prevention

Guangzhou, Guangdong, China

About this study

This is a pilot RCT, and the primary outcomes of this study are: 1) to test the feasibility and acceptability of the crowdsourced intervention, and 2) to pilot the preliminary impact of crowdsourced PS intervention in promoting HIV testing among partners of the newly identified HIV cases. In addition, this pilot RCT aimed to collect preliminary data for the designing of a full RCT, which aimed to measure the efficacy of the crowdsourced PS intervention in promoting PS. Thus, the sample size of this study is not designed and will be not powered enough to test the difference between the two arms. However, with a sample size of 120 (80 for intervention arm and 40 for the control arm, respectively), this pilot study would be able to observe the differences between the two arms and collect preliminary data for adequate sample size calculation of a full RCT. With a sample size of 120 (ratio of 2:1), alpha=0.05, power=0.80, and the partner return rate in the conventional PS arm is 30% (around 31% in 2016 in Guangzhou), the minimal detectable effect size would be 26.7% for this pilot study.

Data analyses: For the primary outcomes of feasibility and acceptability of the intervention: this will be analyzed through descriptive analysis to assess the feedback on the feasibility and acceptability of the crowdsourced PS intervention at baseline and the follow-up survey. For the primary outcome of the proportion of partners returning for HIV testing within 2 months of the index participant's enrolment in the study, log-binomial regression (generalized linear model with binomial distribution and log link) will be used to calculate 95% confidence intervals for the proportion of notifiable partners visiting by arm. Risk differences and risk ratios will also be calculated in these models. As this study is a pilot RCT, adjustment for covariates is not necessary and will not be conducted in the primary analysis. In secondary analyses, pre-specified potential confounding variables will be adjusted that might bias the estimate if not accounted for (e.g. index age, index marital status). If a partner reports more than one index referred him, he will be counted as a returning partner for each identified index.

Subgroup analyses will be performed by partner sex, partner type (e.g. main male partner vs. casual male partner) and sexual orientation. Time to presentation will also be assessed among all notifiable partners using Cox proportional hazards with a robust variance estimator. In the time-to-event analyses, censoring will occur at the end of 2-months. Note that for the primary outcome, the assumption is that any partner without an identifiable record at the community center or in the centralized electronic medical record (EMR) did not present for HIV testing. Therefore, this study assumes no missing outcome data. Sensitivity analyses will be conducted using alternative definitions of presentation for testing, including using the self-reported data from index cases and partners. For count variables expressed as the mean number of partners, the investigators will use either Poisson regression or negative binomial regression if overdispersion is identified.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • born biologically male,
  • aged 18 years old or older,
  • newly identified as HIV positive,
  • had oral or anal sex with a man,
  • had at least one sexual partner in the previous 6 months
  • live in Guangzhou

Exclusion criteria

  • Not meet inclusion criteria
  • Not given informed consent

Treatment and study plan

Crowdsourced partner services intervention

Combination Product

The intervention includes the provision of provider referral and dual referral services, crowdsourced materials such as postcards and an HTML aiming to promote PS, as well as free take-home HIV self-testing kits.

Primary outcomes

  1. Percentage of MSM Index Cases That Respond to the Follow-up Survey at 3 Months After Enrollment

    Time frame: 3 months post enrollment

    Intervention feasibility, measured by the percentage of MSM index cases that respond to the follow-up survey 3 months after enrollment

  2. Acceptability Degree of the Intervention Using an Acceptability Questionnaire

    Time frame: 3 months post enrollment

    Intervention acceptability, measured by the mean score of an acceptability questionnaire among index patients in the intervention group at 3-month follow-up. The questionnaire asks index patients about their responses to statements regarding the acceptability of the crowdsourced intervention materials, and is rated on a 1-5 scale with mean scores ranging between 1 and 5, where 1 means 'strongly disagree' and 5 means 'strongly agree'. Higher mean scores mean higher acceptability.

  3. Percentage of Partners Who Perform HIV-testing Within 3 Months of the Index Patient's Enrollment

    Time frame: 3 months post enrollment

    The preliminary impact of the intervention, measured by the percentage of partners who perform HIV-testing within 3 months of the index patient's enrollment. Partner HIV testing is self-reported by the index, and verified by the partners uploading testing results.

Secondary outcomes

  1. Percentage of Partners Who Were Notified Within 3 Months of the Index's Enrollment

    Time frame: 3 months post enrollment

    The percentage of partners who were notified by their indexes within 3 months of the index's enrollment

  2. Mean Number of Partners Tested Per Index

    Time frame: 3 months post enrollment

    The mean number of sexual partners tested per index followed for the last 3 months.

  3. Percentage of Partners Who Have Positive HIV Tests Among All Tested Partners

    Time frame: 3 months post enrollment

    The percentage of partners tested as HIV positive among partners who performed HIV-testing in the last 3 months.

  4. Mean Number of Case-finding Per Index

    Time frame: 3 months post enrollment

    The mean number of case-finding (i.e., partners tested positive) per index within 3 months post index enrollment

  5. Percentage of Casual Male Partners Getting HIV Testing

    Time frame: 3 months post enrollment

    The percentage of partners getting HIV testing who are not spouses or regular male partners

  6. Percentage of Presenting Partners Reporting Condom Use During the Last Anal Intercourse

    Time frame: 3 months post enrollment

    The percentage of presenting partners who completed the partner survey and reported condom use during the last anal intercourse

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Official study title

Enhancing Partner Services Among Men Who Have Sex With Men Living With HIV: A Pilot Randomized Controlled Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jul 22, 2021
Registry last updated
Jun 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.